CLEAR CELL CARCINOMA OF THE ENDOMETRIUM

Clinical trials for CLEAR CELL CARCINOMA OF THE ENDOMETRIUM explained in plain language.

Never miss a new study

Get alerted when new CLEAR CELL CARCINOMA OF THE ENDOMETRIUM trials appear

Sign up with your email to follow new studies for CLEAR CELL CARCINOMA OF THE ENDOMETRIUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for rare ovarian cancer: immunotherapy combo tested in phase II trial

Disease control Recruiting now

This phase II trial is testing whether the immunotherapy drug dostarlimab, alone or combined with bevacizumab, can control recurrent gynecological clear cell carcinoma better than standard chemotherapy. About 198 women with this rare cancer type will be randomly assigned to one o…

Matched conditions: CLEAR CELL CARCINOMA OF THE ENDOMETRIUM

Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control

Last updated Jun 27, 2026 12:29 UTC

CLEAR CELL CARCINOMA OF THE ENDOMETRIUM

Get alerted when new CLEAR CELL CARCINOMA OF THE ENDOMETRIUM trials appear

New hope for rare ovarian cancer: immunotherapy combo tested in phase II trial